Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for Stroke [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety of intranasal administration of cultured allogeneic umbilical cord-derived mesenchymal stem cell exosomes fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Allogeneic umbilical cord-derived mesenchymal stem cell exosome intranasal therapy

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Stroke | Phase 1 | Status: RECRUITING